ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Antibodies"

  • 2016 American Transplant Congress

    Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients.

    S. Patel, S. Kuten, R. Knight, D. Nguyen, E. Graviss, A. Gaber.

    Houston Methodist Hospital, Houston, TX.

    Recent literature indicates an elevated rate of de novo DSA (dnDSA) following BK viremia (BKV) in renal transplant recipients (RTR). We sought to review our…
  • 2016 American Transplant Congress

    Impact of Pretransplant Non-Donor-Specific HLA Immunization: Mainly Class 1 Immunization Leads to Poor Immunologic Outcome and Graft Loss.

    O. Staeck, F. Halleck, A. Staeck, L. Lehner, M. Duerr, E. Schrezenmeier, K. Budde, D. Khadzhynov.

    Nephrology, Charite, Berlin, Germany.

    Background Anti-HLA immunization measured as Panel Reactive Antibodies (PRA) is known to have a negative impact on patient and graft survival. The influence of pre-transplant…
  • 2016 American Transplant Congress

    Exosome-Like Vesicles Released in Association with Tissue Injury Trigger Anti-LG3 Production.

    M. Dieudé,1,2,3 J. Turgeon,1,3 B. Yang,1,2,3 L. Pomerleau,1,3 K. Hamelin,1,3 S. Lan,1,2,3 S. Qi,1,3 D. Gingras,1,3 W. Dhari,1 A. Rivard,1 M.-J. Hébert.1,2,3

    1Research Centre, Centre hospitalier de l'Université de Montréal, Montréal, Canada; 2Université de Montréal, Montréal, Canada; 3Canadian National Transplantation Research Program, Edmonton, Canada.

    Pre-transplant levels of autoantibodies to perlecan/LG3 predict poor allograft outcomes in renal transplant patients. We showed previously thatapoptotic exosome-like vesicles (ApoExo) enhance anti-LG3 production and…
  • 2016 American Transplant Congress

    Glomerular Capillary C4d Staining without Evidence of Rejection Is Associated with Worse Graft Function in ABO-Incompatible Kidney Transplantation.

    D. Toki,1 M. Inui,1 M. Okumi,2 H. Ishida,2 K. Setoguchi,1 T. Shimizu,2 K. Unagami,2 K. Tanabe.2

    1Urology, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan; 2Urology, Tokyo Women's Medical University, Tokyo, Japan.

    Objectives: C4d staining in the peritubular capillaries (C4d-PTC) is often observed without evidence of rejection in ABO-incompatible kidney transplantation (ABOI-KTx), and this phenomenon is generally…
  • 2016 American Transplant Congress

    Real Time Assessment of Kidney Transplant Indication Biopsies by Microarrays: First Results of the INTERCOMEX Study.

    P. Halloran,1,2 J. Reeve,1 INTERCOMEX Study Group.

    1University of Alberta, Edmonton, Canada; 2ATAGC, Edmonton, Canada.

    Oncology uses central molecular tissue assessment (MTA) to guide management but the potential of this approach in transplantation is not known. We undertook a prospective…
  • 2016 American Transplant Congress

    Blocking Fc Receptor in Flow Cytometric Crossmatch: Refining an Old Assay to Improve Patient Management.

    N. Brown, J. Wang, S. Marino.

    Pathology, University of Chicago, Chicago, IL.

    Introduction: The crossmatch assay is used to determine sensitization of solid organ transplant recipients to donor-expressed HLA molecules, a potential contraindication to transplant. Multicolor flow…
  • 2016 American Transplant Congress

    Distinct Effects of Chronic Hyperglycemia on Cellular and Humoral Alloresponses In Vivo.

    N. Bishop,1 K. Beard,2 R. Gill.2

    1Immunology and Microbiology, University of Colorado Denver, Aurora, CO; 2Surgery, University of Colorado Denver, Aurora, CO; 3Surgery, University of Colorado Denver, Aurora, CO.

    Background: Diabetes constitutes a significant problem in the transplant recipient. Diabetes is associated with impaired immunity to pathogens but its effect on alloimmunity remains ambiguous.…
  • 2016 American Transplant Congress

    The Coefficient of Variability of Tacrolimus Levels Can Predict Antibody-Mediated Rejection After Renal Transplantation.

    P. Ruiz-Esteban,1 M. Gonzalez-Molina,1 A. Caballero,2 E. Palma,1 D. Burgos,1 M. Cabello,1 J. Alonso-Titos,1 A. Duarte,1 D. Hernandez.1

    1Nephrology, Regional Universitary Hospital, IBIMA, University of Malaga, Malaga, Spain; 2Immunology, Regional University Hospital, IBIMA, University of Malaga, Malaga, Spain.

    Introduction. Antibody-mediated rejection (ABMR) is the major cause of allograft failure. We studied whether the coefficient of variability (CV) of blood levels of tacrolimus can…
  • 2016 American Transplant Congress

    Natural Killer CD16/FcR Profiles May Associate with Enhanced Humoral Responsiveness in Heart Transplant Recipients with Cardiac Allograft Vasculopathy.

    P. Paul,1,2 C. Picard,3,4 E. Sampol,5 L. Lyonnet,1 J. Di Cristofaro,3,4 G. Lano,6, B. Dussol,6, F. Collart,7 F. Sabatier,1,2 F. Dignat George,1,2 A. Mouly Bandini.7

    1Hematology, Assistance Publique-Hopitaux Marseille (AP-HM), Marseille, France; 2UMR-1076, Aix Marseille Université (AMU), INSERM, Marseille, France; 3Établissement Français du Sang, Marseille, France; 4UMR7268, AMU, CNRS, Marseille, France; 5Pharmacokinetics, AP-HM, Marseille, France; 6Center for Clinical Investigation, AP-HM, Marseille, France; 7Cardiac Surgery, AP-HM, Marseille, France.

    Natural Killer cells (NK) are immune effectors of antibody-dependent cellular cytotoxicity (ADCC). Their role in mediating adverse effects of Donor-specific anti-HLA antibodies (DSA) towards cardiac…
  • 2016 American Transplant Congress

    IgM Donor Specific Antibodies Are Frequently Associated with C1q-binding DnDSA in Renal Transplant Recipients.

    J. Bamoulid,3 A. Roodenburg,4 O. Staeck,1 C. Schoenemann,2 N. Lachmann,2 K. Budde.1

    1Nephrologie, Charite Universität Medizin, Berlin, Germany; 2HLA Labor, Charite Universität Medizin, Berlin, Germany; 3Nephrologie, CHU Jean Minjoz, Besançon, France; 4Erasmus Medical Centre, Rotterdam, Netherlands.

    Background: Recently, the importance of complement-binding de novo DSA (dnDSA) was documented. We aimed to explore the presence of IgM dnDSA according to C1q dnDSA-binding…
  • « Previous Page
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • 57
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences